Entera Bio Ltd.
NASDAQ:ENTX
1.79 (USD) • At close April 17, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||
| Net Income
| -9.541 | -8.889 | -13.071 | -12.187 | -9.983 | -10.795 | -10.304 | -11.197 | -1.199 | -4.282 |
| Depreciation & Amortization
| 0.046 | 0.056 | 0.064 | 0.053 | 0.225 | 0.238 | 0.054 | 0.043 | 0.035 | 0.028 |
| Deferred Income Tax
| 0.014 | 0.029 | 0.174 | -0.217 | -0.033 | 0.033 | -0.041 | -0.324 | 0.022 | 0 |
| Stock Based Compensation
| 2.556 | 1.689 | 2.247 | 1.861 | 0.901 | 1.483 | 1.233 | 4.885 | 1.49 | 0.366 |
| Change In Working Capital
| 0.112 | -0.195 | -1.835 | 1.409 | -0.351 | 0.691 | -0.506 | 0.909 | 0.353 | -0.183 |
| Accounts Receivables
| -0.126 | 0.246 | -0.063 | 0.072 | 0.023 | 0.447 | -0.725 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | -0.072 | -0.095 | 0.341 | 0.117 | 0 | 0 | 0 |
| Accounts Payables
| 0.049 | 0.066 | -0.149 | 0.074 | -0.17 | -0.139 | -0.123 | 0.543 | -0.298 | 0.227 |
| Other Working Capital
| 0.189 | -0.507 | -1.623 | 1.335 | -0.109 | 0.042 | 0.225 | 0.366 | 0.651 | -0.41 |
| Other Non Cash Items
| -0.005 | 0 | -0.078 | 0.018 | -1.182 | -0.569 | -0.232 | 1.158 | -3.843 | 0.576 |
| Operating Cash Flow
| -6.818 | -7.31 | -12.499 | -9.063 | -10.423 | -8.919 | -9.796 | -4.526 | -3.142 | -3.495 |
| Investing Activities: | ||||||||||
| Investments In Property Plant And Equipment
| -0.003 | -0.017 | -0.047 | -0.017 | -0.053 | -0.04 | -0.068 | -0.051 | -0.041 | -0.054 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | -4 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | 0 | -0.055 | 0 | -0.033 | 3.986 | -4 | 1.053 | -1.075 | 0 |
| Investing Cash Flow
| -0.003 | -0.017 | -0.102 | -0.017 | -0.086 | 3.946 | -4.068 | 1.002 | -1.116 | -0.054 |
| Financing Activities: | ||||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | -0.136 | -0.114 | 0 | -0.98 | 7.216 | 2.005 |
| Common Stock Issued
| 3.96 | 6.616 | 0.013 | 21.805 | 3.983 | 12.528 | 9.624 | 12.087 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0.516 | -0.58 | 0.013 | 3.576 | 0.204 | 0.238 | 0 | 12.087 | 0 | 2.46 |
| Financing Cash Flow
| 4.476 | 6.036 | 0.013 | 25.381 | 3.917 | 12.652 | 9.624 | 11.107 | 7.216 | 4.465 |
| Other Information: | ||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.001 |
| Net Change In Cash
| -2.345 | -1.291 | -12.588 | 16.301 | -6.592 | 7.679 | -4.24 | 7.583 | 2.958 | 0.915 |
| Cash At End Of Period
| 8.74 | 11.085 | 12.376 | 24.964 | 8.593 | 15.185 | 7.506 | 11.746 | 4.163 | 1.205 |